The Impact of Opioid Risk Reduction Initiatives on High-Dose Opioid Prescribing for Patients on Chronic Opioid Therapy
- 1 January 2016
- journal article
- Published by Elsevier in The Journal of Pain
- Vol. 17 (1) , 101-110
Abstract
No abstract availableKeywords
Funding Information
- Pfizer
- Patient-Centered Outcomes Research Institute (IHS-1306-02198)
- National Institute on Aging (AG034181)
This publication has 20 references indexed in Scilit:
- Bending the prescription opioid dosing and mortality curves: Impact of the Washington State opioid dosing guidelineAmerican Journal of Industrial Medicine, 2011
- Group Health’s Initiative To Avert Opioid Misuse And Overdose Among Patients With Chronic Noncancer PainHealth Affairs, 2011
- Risks for opioid abuse and dependence among recipients of chronic opioid therapy: Results from the TROUP StudyDrug and Alcohol Dependence, 2010
- Hospitalizations for Poisoning by Prescription Opioids, Sedatives, and TranquilizersAmerican Journal of Preventive Medicine, 2010
- Problems and concerns of patients receiving chronic opioid therapy for chronic non-cancer painPain, 2010
- De Facto Long-term Opioid Therapy for Noncancer PainThe Clinical Journal of Pain, 2008
- Major increases in opioid analgesic abuse in the United States: Concerns and strategiesDrug and Alcohol Dependence, 2006
- Diffusion of Innovations in Service Organizations: Systematic Review and RecommendationsThe Milbank Quarterly, 2004
- Segmented regression analysis of interrupted time series studies in medication use researchJournal of Clinical Pharmacy and Therapeutics, 2002
- Tests of statistical hypotheses concerning several parameters when the number of observations is largeTransactions of the American Mathematical Society, 1943